Expression of mRNA for the GATA-binding proteins in human eosinophils and basophils: potential role in gene transcription.

The expression of the hematopoietic transcription factors GATA-1, GATA-2, and GATA-3 was studied in eosinophils and basophils. Eosinophils express mRNA for GATA-1, GATA-2, and GATA-3. Basophils express GATA-2 and GATA-3. Treatment of HL-60 eosinophilic sublines with either interleukin-5 or butyric acid increased the expression of GATA-1 mRNA concomitant with the expression of eosinophil-specific genes, whereas levels of GATA-2 mRNA remained relatively constant. The presence of mRNA for these proteins in eosinophils and basophils suggests that gene transcription in these lineages may be regulated by GATA-binding proteins.

[1]  D. Tenen,et al.  Molecular cloning and characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). Similarities to IgE binding proteins and the S-type animal lectin superfamily. , 1993, Journal of immunology.

[2]  L. Zon,et al.  Cell cycle-dependent initiation and lineage-dependent abrogation of GATA-1 expression in pure differentiating hematopoietic progenitors. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[3]  S. Orkin,et al.  Human transcription factor GATA-2. Evidence for regulation of preproendothelin-1 gene expression in endothelial cells. , 1992, The Journal of biological chemistry.

[4]  M. Vadas,et al.  Interleukin-5, interleukin-3, and granulocyte-macrophage colony-stimulating factor cross-compete for binding to cell surface receptors on human eosinophils. , 1991, The Journal of biological chemistry.

[5]  W. Owen,et al.  Eosinophil hematopoietins antagonize the programmed cell death of eosinophils. Cytokine and glucocorticoid effects on eosinophils maintained by endothelial cell-conditioned medium. , 1991, The Journal of clinical investigation.

[6]  L. Zon,et al.  Activation of the erythropoietin receptor promoter by transcription factor GATA-1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[7]  M. L. Beau,et al.  Cellular myosin heavy chain in human leukocytes: isolation of 5' cDNA clones, characterization of the protein, chromosomal localization, and upregulation during myeloid differentiation , 1991 .

[8]  K. Arai,et al.  Expression cloning of the human IL-3 receptor cDNA reveals a shared β subunit for the human IL-3 and GM-CSF receptors , 1991, Cell.

[9]  M. Mattei,et al.  A T‐cell specific TCR delta DNA binding protein is a member of the human GATA family. , 1991, The EMBO journal.

[10]  S. Orkin,et al.  Functional analysis and in vivo footprinting implicate the erythroid transcription factor GATA-1 as a positive regulator of its own promoter. , 1991, Genes & development.

[11]  S. Tsai,et al.  Human GATA‐3: a lineage‐restricted transcription factor that regulates the expression of the T cell receptor alpha gene. , 1991, The EMBO journal.

[12]  J. D. Engel,et al.  Murine and human T-lymphocyte GATA-3 factors mediate transcription through a cis-regulatory element within the human T-cell receptor delta gene enhancer , 1991, Molecular and cellular biology.

[13]  J. Denburg,et al.  Interleukin-5 is a human basophilopoietin: induction of histamine content and basophilic differentiation of HL-60 cells and of peripheral blood basophil-eosinophil progenitors. , 1991, Blood.

[14]  J. Miyazaki,et al.  Transgenic mice expressing a B cell growth and differentiation factor gene (interleukin 5) develop eosinophilia and autoantibody production , 1991, The Journal of experimental medicine.

[15]  S. Orkin,et al.  Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1 , 1991, Nature.

[16]  S. Orkin.  Globin gene regulation and switching: Circa 1990 , 1990, Cell.

[17]  M. Strath,et al.  Eosinophilia in transgenic mice expressing interleukin 5 , 1990, The Journal of experimental medicine.

[18]  A. B. Lyons,et al.  Human Interleukin‐3 inhibits the binding of granulocyte‐macrophage colony‐stimulating factor and interleukin‐5 to basophils and strongly enhances their functional activity , 1990, Journal of cellular physiology.

[19]  J. D. Engel,et al.  Activity and tissue-specific expression of the transcription factor NF-E1 multigene family. , 1990, Genes & development.

[20]  A. Jarman,et al.  A major positive regulatory region located far upstream of the human alpha-globin gene locus. , 1990, Genes & development.

[21]  J. Tavernier,et al.  Characterization of interleukin 5 receptors on eosinophilic sublines from human promyelocytic leukemia (HL-60) cells , 1990, The Journal of experimental medicine.

[22]  F. Grosveld,et al.  The beta‐globin dominant control region: hypersensitive site 2. , 1990, The EMBO journal.

[23]  F. Grosveld,et al.  Detailed analysis of the site 3 region of the human beta‐globin dominant control region. , 1990, The EMBO journal.

[24]  Stuart H. Orkin,et al.  Expression of an erythroid transcription factor in megakaryocytic and mast cell lineages , 1990, Nature.

[25]  W. Vainchenker,et al.  Megakaryocytic and erythrocytic lineages share specific transcription factors , 1990, Nature.

[26]  R. L. Barker,et al.  Cloning and sequence analysis of the human gene encoding eosinophil major basic protein. , 1990, Gene.

[27]  G. Felsenfeld,et al.  The erythroid-specific transcription factor eryf1: A new finger protein , 1989, Cell.

[28]  P. Romeo,et al.  Cis- and trans-acting elements involved in the regulation of the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[29]  D. Tenen,et al.  Human eosinophil cationic protein. Molecular cloning of a cytotoxin and helminthotoxin with ribonuclease activity , 1989, The Journal of experimental medicine.

[30]  A. Sheffer,et al.  Interleukin 5 and phenotypically altered eosinophils in the blood of patients with the idiopathic hypereosinophilic syndrome , 1989, The Journal of experimental medicine.

[31]  Shih-Feng Tsai,et al.  Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells , 1989, Nature.

[32]  D. Tenen,et al.  Molecular cloning of the human eosinophil-derived neurotoxin: a member of the ribonuclease gene family. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[33]  P. Valent,et al.  Interleukin-3 is a differentiation factor for human basophils. , 1989, Blood.

[34]  J. D. Engel,et al.  Transcription of the chicken histone H5 gene is mediated by distinct tissue-specific elements within the promoter and the 3' enhancer , 1989, Molecular and cellular biology.

[35]  F. Grosveld,et al.  Two tissue-specific factors bind the erythroid promoter of the human porphobilinogen deaminase gene. , 1989, Nucleic acids research.

[36]  F. Grosveld,et al.  The human beta-globin gene 3' enhancer contains multiple binding sites for an erythroid-specific protein. , 1988, Genes & development.

[37]  A. Dvorak,et al.  Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to a distinct crystalloid-free granule population in mature human eosinophils. , 1988, Blood.

[38]  T. Suda,et al.  Highly purified murine interleukin 5 (IL-5) stimulates eosinophil function and prolongs in vitro survival. IL-5 as an eosinophil chemotactic factor , 1988, The Journal of experimental medicine.

[39]  A. Donnenberg,et al.  Selective differentiation and proliferation of hematopoietic cells induced by recombinant human interleukins. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[40]  T. Suda,et al.  Purified interleukin 5 supports the terminal differentiation and proliferation of murine eosinophilic precursors , 1988, The Journal of experimental medicine.

[41]  U. Jäger,et al.  Human blood basophils display a unique phenotype including activation linked membrane structures. , 1987, Blood.

[42]  Michael P. Bodger,et al.  The purification of human basophils: their immunophenotype and cytochemistry , 1987, British journal of haematology.

[43]  P. H. Fitzgerald,et al.  A monoclonal antibody reacting with human basophils. , 1987, Blood.

[44]  M. Tomonaga,et al.  Establishment of eosinophilic sublines from human promyelocytic leukemia (HL-60) cells: demonstration of multipotentiality and single-lineage commitment of HL-60 stem cells. , 1986, Blood.

[45]  J. Denburg,et al.  Heterogeneity of human peripheral blood eosinophil-type colonies: evidence for a common basophil-eosinophil progenitor. , 1985, Blood.

[46]  K. Austen,et al.  Biochemical characterization of human eosinophil Charcot-Leyden crystal protein (lysophospholipase). , 1984, The Journal of biological chemistry.

[47]  P. Arcari,et al.  The complete sequence of a full length cDNA for human liver glyceraldehyde-3-phosphate dehydrogenase: evidence for multiple mRNA species. , 1984, Nucleic acids research.

[48]  G. Gleich,et al.  Stimulation of basophil and rat mast cell histamine release by eosinophil granule-derived cationic proteins. , 1984, Journal of immunology.

[49]  J. Testa,et al.  Eosinophilic differentiation of the human promyelocytic leukemia cell line, HL-60 , 1984, The Journal of experimental medicine.

[50]  J. Harley,et al.  Distinctive cationic proteins of the human eosinophil granule: major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin. , 1983, Journal of immunology.

[51]  B. Spiegelman,et al.  Molecular cloning of mRNA from 3T3 adipocytes. Regulation of mRNA content for glycerophosphate dehydrogenase and other differentiation-dependent proteins during adipocyte development. , 1983, The Journal of biological chemistry.

[52]  G. Gleich,et al.  Activation of basophil and mast cell histamine release by eosinophil granule major basic protein , 1983, The Journal of experimental medicine.

[53]  G. Gleich,et al.  Formation of Charcot-Leyden crystals by human basophils , 1982, The Journal of experimental medicine.

[54]  D. Loegering,et al.  The human eosinophil Charcot-Leyden crystal protein: biochemical characteristics and measurement by radioimmunoassay. , 1980, Journal of immunology.

[55]  W. Rutter,et al.  Isolation of biologically active ribonucleic acid from sources enriched in ribonuclease. , 1979, Biochemistry.

[56]  J. Tavernier,et al.  A human high affinity interleukin-5 receptor (IL5R) is composed of an IL5-specific alpha chain and a beta chain shared with the receptor for GM-CSF. , 1991, Cell.

[57]  J. Bazan,et al.  Haemopoietic receptors and helical cytokines. , 1990, Immunology today.

[58]  L. Zon,et al.  The major human erythroid DNA-binding protein (GF-1): primary sequence and localization of the gene to the X chromosome. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[59]  M. Muhm,et al.  Further characterization of surface membrane structures expressed on human basophils and mast cells. , 1990, International archives of allergy and applied immunology.

[60]  V. Casolaro,et al.  Pathophysiology of human basophils and mast cells in allergic disorders. , 1989, Clinical immunology and immunopathology.

[61]  A. Dvorak,et al.  Ultrastructural localization of the Charcot-Leyden crystal protein (lysophospholipase) to granules and intragranular crystals in mature human basophils. , 1989, Laboratory investigation; a journal of technical methods and pathology.

[62]  S. Fischkoff.  Graded increase in probability of eosinophilic differentiation of HL-60 promyelocytic leukemia cells induced by culture under alkaline conditions. , 1988, Leukemia research.

[63]  J. Denburg,et al.  Sodium butyrate and a T lymphocyte cell line-derived differentiation factor induce basophilic differentiation of the human promyelocytic leukemia cell line HL-60. , 1988, Blood.

[64]  J. David,et al.  The regulation of human eosinophil function by cytokines. , 1987, Immunology today.

[65]  Victor V Lobanenkov,et al.  Characterisation of chicken erythroid nuclear proteins which bind to the nuclease hypersensitive regions upstream of the beta A- and beta H-globin genes. , 1986, Nucleic acids research.

[66]  G. Gleich,et al.  The eosinophilic leukocyte: structure and function. , 1986, Advances in immunology.

[67]  A. Butterworth.  Cell-mediated damage to helminths. , 1984, Advances in parasitology.